(Q44588114)

4 December 2017

title

Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist (English)

1 reference

paroxysmal supraventricular tachycardia

4 December 2017

main subject

0 references

author

Kenneth A. Ellenbogen

6

object named as

Kenneth Ellenbogen

1 reference

4 December 2017

Eric N Prystowsky

1

1 reference

4 December 2017

Imran Niazi

2

1 reference

4 December 2017

Anne B Curtis

3

1 reference

4 December 2017

David J Wilber

4

1 reference

4 December 2017

Tristram Bahnson

5

1 reference

4 December 2017

Anwer Dhala

7

1 reference

4 December 2017

Daniel M Bloomfield

8

1 reference

4 December 2017

Michael Gold

9

1 reference

4 December 2017

Alan Kadish

10

1 reference

4 December 2017

Richard I Fogel

11

1 reference

4 December 2017

Mario D Gonzalez

12

1 reference

4 December 2017

Luiz Belardinelli

13

1 reference

4 December 2017

Revati Shreeniwas

14

1 reference

4 December 2017

Andrew A Wolff

15

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1098-1102

1 reference

The cardiac effects of adenosine

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Effects of adenosine on atrial refractoriness and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Effects of adenosine on rate-dependent atrioventricular nodal function. Potential roles in tachycardia termination and physiological regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Rate-dependent properties of adenosine-induced negative dromotropism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

A partial agonist of the A(1)-adenosine receptor selectively slows AV conduction in guinea pig hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Electrophysiologic effects of adenosine in patients with supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Adenosine-induced atrial arrhythmia: a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

Adenosine induced ventricular arrhythmias in the emergency room

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900987-2

7 January 2021

10.1016/S0735-1097(03)00987-2

Identifiers

DOI

1 reference

4 December 2017

1 reference